• Anlotinib Inhibits Angiogenesis Through Three Kinases

  2026-08-25

  The reference study shows that anlotinib suppresses angiogenesis by inhibiting VEGFR2, PDGFRβ, and FGFR1 together with their downstream ERK signaling pathway. Its multi-factor assay design links endothelial migration, capillary-like tube formation, ex vivo vessel sprouting, and CAM neovascularization, providing a useful framework for cancer research.

• FDA-Approved Screening Identifies MERS-CoV Inhibitors

  2026-08-25

  The reference study screened 348 FDA-approved drugs in cell culture and identified chloroquine, chlorpromazine, loperamide, and lopinavir as low-micromolar inhibitors of MERS-CoV replication. Its main contribution was to show how phenotypic repurposing can rapidly generate cross-coronavirus antiviral leads, while also demonstrating that cell-based activity requires further validation before therapeutic conclusions are possible.

• SARS-CoV-2 N Condensates as an Antiviral Target

  2026-08-24

  The reference study identifies RNA-triggered liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a functional step in viral biology. It further shows that (-)-gallocatechin gallate disrupts N–RNA condensation and suppresses viral replication, establishing condensate control as a mechanistic antiviral strategy while highlighting important questions about specificity and translation.

• Sunitinib: Multi-Targeted RTK Inhibitor

  2026-08-24

  Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that blocks VEGFR, PDGFR, KIT, and RET signaling. Its research value spans tumor angiogenesis, apoptosis induction in renal cell carcinoma, cell cycle arrest at G0/G1 phase, and studies of resistance mechanisms.

• Live-Dead Cell Staining Kit for Biomaterial Testing

  2026-08-23

  Discover how the Live-Dead Cell Staining Kit can become a decision tool for evaluating biomaterial cytocompatibility, not merely a binary viability endpoint. This article connects Calcein-AM Propidium Iodide staining with mechanistic testing of multifunctional hemostatic adhesives.

• Bsa I (RNase-free): Protocol and QC Guide

  2026-08-22

  Bsa I (RNase-free) provides sequence-directed DNA cleavage for gene cloning, DNA manipulation, and other molecular biology research workflows in which RNase control is important. It is intended for scientific research only and should not be used for diagnostic, clinical, or medical applications.

• TRIB3, Ferroptosis, and Sunitinib Sensitivity in ccRCC

  2026-08-21

  A 2024 Cellular Signalling study identifies TRIB3 knockdown as a strategy for increasing clear cell renal cell carcinoma sensitivity to Sunitinib. The work links TRIB3 depletion to ferroptosis through the SLC7A11/GPX4 antioxidant axis, providing a mechanistic framework for studying resistance beyond conventional RTK signaling.

• MEDUSA Reveals Hidden Drug-Death Mechanisms

  2026-08-21

  Honeywell and colleagues introduce MEDUSA, a time-resolved modeling framework that separates drug-induced growth inhibition from cell death in pooled functional genomic screens. Applied to DNA damage responses, the method shows that p53 loss can redirect lethality from apoptosis toward a respiration-dependent nonapoptotic process, offering a stronger basis for interpreting resistance and combination strategies.

• Perospirone (SM-9018 freebase): Assay Guide

  2026-08-20

  This scenario-based guide explains how Perospirone (SM-9018 freebase), SKU BA5009, can be incorporated into viability, proliferation, receptor, and vascular ion-channel experiments. It emphasizes solvent compatibility, concentration design, controls, and interpretation of neurovascular findings without treating one assay endpoint as a complete mechanism.

• Biotin for STING Assays and Protein Labeling

  2026-08-20

  Biotin (Vitamin B7) connects cofactor biology with high-sensitivity molecular detection, from carboxylase assays to streptavidin-enabled analysis of antiviral signaling. This guide shows how to adapt biotinylation workflows for STING-pathway experiments while avoiding solubility, background, and labeling-specific failure modes.

• AP20187: Reliable Cell Assay Workflows

  2026-08-19

  A scenario-driven guide to using AP20187 (SKU B1274) as a chemical inducer of dimerization in cell viability, proliferation, and cytotoxicity workflows. It connects formulation, controls, protocol optimization, interpretation, and vendor-selection decisions to practical laboratory needs.

• ABT-199 and the Logic of Mitochondrial Cell Death

  2026-08-19

  ABT-199 (Venetoclax) offers a precise way to interrogate BCL-2-dependent survival in hematologic malignancy models. This article connects its mitochondrial selectivity with a recent Pol II-degradation study to improve causal interpretation in apoptosis assays.

• AG-126: Mapping ERK Signals in D2-MSN Research

  2026-08-18

  AG-126 (Tyrphostin AG-126) provides a pharmacological way to test ERK1/2 involvement in striatal D2-MSN phenotypes. This article presents an evidence-aware assay strategy that separates ERK signaling from the PKC and circuit mechanisms identified in recent Neuroligin 1 research.

• Vernakalant Hydrochloride Research Workflows

  2026-08-18

  Build atrial-selective electrophysiology and cardioversion studies around Vernakalant Hydrochloride (RSD1235), from ion-channel assays to translational AF models. Practical concentration, handling, controls, and troubleshooting guidance help distinguish true frequency-dependent pharmacology from assay artifacts.

• A40926 Workflow for Antibacterial Research

  2026-08-17

  A40926 is a dalbavancin precursor that links mechanistic cell-wall studies with practical antibacterial screening. This guide shows how to build reproducible assays, investigate MRSA and Neisseria gonorrhoeae inhibition, and use pathway-regulator insights to improve production workflows.

7895 records 1/527 page Next 12345 下5页 Last page